- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating tumor DNA in Hodgkin lymphoma ; volume:101 ; number:11 ; day:8 ; month:9 ; year:2022 ; pages:2393-2403 ; date:11.2022
Annals of hematology ; 101, Heft 11 (8.9.2022), 2393-2403, 11.2022
- Creator
-
Maco, Maria
Kupcova, Kristyna
Herman, Vaclav
Ondeckova, Iva
Kozak, Tomas
Mocikova, Heidi
Havranek, Ondrej
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-022-04949-x
- URN
-
urn:nbn:de:101:1-2022122321020972408411
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maco, Maria
- Kupcova, Kristyna
- Herman, Vaclav
- Ondeckova, Iva
- Kozak, Tomas
- Mocikova, Heidi
- Havranek, Ondrej
- SpringerLink (Online service)
Other Objects (12)
Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Noninvasive CNS lymphoma risk stratification and brain cancer classification by circulating tumor DNA profiling
Radiotherapy for Hodgkin lymphoma
Primary gastric Hodgkin's lymphoma
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma
ALK Negative Inflammatory Myofibroblastic Tumor Synchronous with Classical Hodgkin Lymphoma
Cell-free circulating tumor DNA in cancer
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Noninvasive CNS lymphoma risk stratification and brain cancer classification by circulating tumor DNA profiling
Radiotherapy for Hodgkin lymphoma
Primary gastric Hodgkin's lymphoma
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma
ALK Negative Inflammatory Myofibroblastic Tumor Synchronous with Classical Hodgkin Lymphoma
Cell-free circulating tumor DNA in cancer
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Noninvasive CNS lymphoma risk stratification and brain cancer classification by circulating tumor DNA profiling
Radiotherapy for Hodgkin lymphoma
Primary gastric Hodgkin's lymphoma
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma
ALK Negative Inflammatory Myofibroblastic Tumor Synchronous with Classical Hodgkin Lymphoma
Cell-free circulating tumor DNA in cancer
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research